UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Determination of apatinib and its three active metabolites by UPLC-MS/MS in a Phase IV clinical trial in NSCLC patients Journal article
Guan, Shaoxing, Shi, Wei, Zhao, Zerui, Wang, Fei, Jiang, Fulin, Zhang, Caibin, Jin, Zhongming, Guan, Yanping, Liu, Dihan, Zhong, Guoping, Huang, Min, Long, Hao, Wang, Xueding. Determination of apatinib and its three active metabolites by UPLC-MS/MS in a Phase IV clinical trial in NSCLC patients[J]. Bioanalysis, 2019, 11(22), 2049-2060.
Authors:  Guan, Shaoxing;  Shi, Wei;  Zhao, Zerui;  Wang, Fei;  Jiang, Fulin; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:1.9/2.1 | Submit date:2022/05/23
Active Metabolites  Apatinib  Therapeutic Drug Monitoring  Uplc-ms/ms